Sign up
 Automatic website change logs and notification

|  Home  |  Webmasters  |  Directory  |  Compare  |  Help  

 

Press Releases



Current status: Connection error: 404 Page Not Found
Number of users monitoring this page: 0
Most recent sizable change (text, html) : 2018-08-03 05:53
Most recent change (text, html) : 2018-08-03 05:53
Last checked for changes: 2018-10-07 07:20
ChangeDetection started monitoring: 2017-05-18 05:53
Add search to your site

Add a search engine to your website today,
for free, in less than ten minutes.

FreeFind.com

monitor this page

Page Address:
Send alert to:

summary of most recent changes

Showing 1 - 5 of 27 1 2 3 4 [next]

View changes:  2018-08-03 05:53    103 new words, 0 deleted words, 1% change   
... | 2015 Date Title 08/02/18 Corvus Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update BURLINGAME, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals ... , and provided a business update. We continue to be a leader in programs addressing the adenosine pathway, with three clinical trials currently enrolling and more than 235 patients treate... ... | 2015 Date Title 08/02/18 Corvus Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update BURLINGAME, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals ... , and provided a business update. We continue to be a leader in programs addressing the adenosine pathway, with three clinical trials currently enrolling and more than 235 patients treate... 07/31/ ... | 2015 Date Title ... 07/31/    more...

View changes:  2018-08-01 05:53    106 new words, 0 deleted words, 1% change   
... | 2015 Date Title 07/31/18 Corvus Pharmaceuticals to Present at 2018 Wedbush PacGrow Healthcare Conference BURLINGAME, Calif., July 31, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a ... Conference in New York. The presentation is scheduled for Wednesday, August 15, at 8:35 a.m. Eastern Time. A webcast of the presentation will be available live and for 90 days fol... 06/28/ ... | 2015 Date Title 07/31/18 Corvus Pharmaceuticals to Present at 2018 Wedbush PacGrow Healthcare Conference BURLINGAME, Calif., July 31, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a ... Conference in New York. The presentation is scheduled for Wednesday, August 15, at 8:35 a.m. Eastern Time. A webcast of the presentation will be available live and for 90 days fol... 06/28/ | 2015 Date Title ... 06/28/    more...

View changes:  2018-06-28 05:53    112 new words, 0 deleted words, 2% change   
... | 2015 Date Title 06/28/18 Corvus Pharmaceuticals Announces Publication of Preclinical Study Results Demonstrating CPI-444 Antitumor Activity as Monotherapy and in Combination with Anti-PD-1 Therapy in Cancer Immunology ... therapies, today announced publication of results of preclinical studies of CPI-444 conducted by researchers at Johns Hopkins University School of Medicine. The data showed that CP... ... | 2015 Date Title 06/28/18 Corvus Pharmaceuticals Announces Publication of Preclinical Study Results Demonstrating CPI-444 Antitumor Activity as Monotherapy and in Combination with Anti-PD-1 Therapy in Cancer Immunology ... therapies, today announced publication of results of preclinical studies of CPI-444 conducted by researchers at Johns Hopkins University School of Medicine. The data showed that CP... ... | 2015 Date Title ... 05/30/    more...

View changes:  2018-05-31 05:55    106 new words, 0 deleted words, 1% change   
... Date Title 05/30/18 Corvus Pharmaceuticals to Present at Jefferies 2018 Global Healthcare Conference BURLINGAME, Calif., May 30, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage ... York. The presentation is scheduled for Wednesday, June 6, at 10:00 a.m. Eastern Time. A webcast of the presentation will be available live and for 30 days foll... 05/03/18 Corvus ... Date Title 05/30/18 Corvus Pharmaceuticals to Present at Jefferies 2018 Global Healthcare Conference BURLINGAME, Calif., May 30, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage ... York. The presentation is scheduled for Wednesday, June 6, at 10:00 a.m. Eastern Time. A webcast of the presentation will be available live and for 30 days foll... 05/03/18 Corvus Date Title 05/... 03/18 Corvus    more...

View changes:  2018-05-04 06:03    101 new words, 0 deleted words, 1% change   
... | 2015 Date Title 05/03/18 Corvus Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update BURLINGAME, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, ... 2018, and provided a business update. We made important progress in advancing our clinical programs and building our pipeline, with several notable developments in the first quarter that rein... ... | 2015 Date Title 05/03/18 Corvus Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update BURLINGAME, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, ... 2018, and provided a business update. We made important progress in advancing our clinical programs and building our pipeline, with several notable developments in the first quarter that rein... 04/26/ ... | 2015 Date Title ... 04/26/    more...


link to this change log

Changes to the page investor.corvuspharma.com/phoenix.zhtml?c=254276&p=irol-news are logged on this page as they are detected. You can link to this log by pasting the HTML below into your page. It produces a link which looks like this: change log

log in


 email
 password
remember me
   

search



 Automatic website change logs and notification

|  Home  |  Webmasters  |  Directory  |  Compare  |  Help  

 
All rights Reserved © 2017 WebMonitoring Technologies Inc. 1900 - 885 West Georgia St. Vancouver, BC V6C 3H4 CA

    home     faq     policies     contact     website panels     tag reference    

Site search technology provided by FreeFind.com and Findia.Net net search